Annual Department Town Hall Meeting with Dean Brown

Transcript

• 00:00Buddy come to our Cancer Center grand
• 00:04rounds and today we have a very special
• 00:07grand rounds with the state of the
• 00:09school and state of the Cancer Center.
• 00:12But Dean Brown, most of you have
• 00:14met her in in the various time
• 00:16she's come and spoken to us.
• 00:18But those of you may be hearing
• 00:20that Dean Brown for the first time.
• 00:21As you know, Dean Brown is
• 00:23the gene and David Wallace,
• 00:24Dean of the School of Medicine and also
• 00:27the CNH longer with internal medicine.
• 00:29She's a Yale alum.
• 00:31She went to undergrad here and was
• 00:33an MVP major and I think arore.
• 00:35From what I recall in earned her
• 00:37medical degree from that other school.
• 00:39But starting with H.
• 00:41And then did majority of her time it
• 00:43at Vanderbilt and training in medicine
• 00:46and a fellowship in nephrology and
• 00:48has a laboratory in basic science
• 00:51focused on transport mechanisms.
• 00:53I think all of you who know Dean Brown
• 00:56also knows she's been committed to the
• 00:58training of the physician scientist
• 01:00and during her tenure at Vanderbilt,
• 01:02started the Elliot Newman Society to
• 01:04support the development of physician
• 01:07scientists and also co-founded the
• 01:09Masters Program for Clinical investigation.
• 01:12She has numerous leadership roles.
• 01:13I don't think I need to go through
• 01:15the all of those,
• 01:16but I think for today's agenda
• 01:19and what we have seen,
• 01:21Nancy as she's arrived.
• 01:22He's LED us through the COVID base,
• 01:24but has also importantly brought the
• 01:27community together in the past 18
• 01:29months that she has been here and
• 01:32having participated in these forums.
• 01:34I will tell you that this is meant
• 01:36to be interactive.
• 01:37I suspect Nancy will give us a
• 01:39little bit of this highlights and
• 01:40then I hope we can.
• 01:42Use the zoom format to ask
• 01:45Dean Brown questions.
• 01:46So with that being brown,
• 01:47welcome to the Cancer Center.
• 01:49We're really happy to have you
• 01:51and talk come and talk to us.
• 01:52Thank
• 01:53you and that's exactly right.
• 01:55I I do these talks and go from
• 01:58department or center to center and
• 02:01I'll review what I call the clip
• 02:03notes of the state of the school and.
• 02:06Try to highlight some particular kudos
• 02:08for members of this Cancer Center.
• 02:10I hope all that will take about 15 to
• 02:1320 minutes and that the remainder of the
• 02:16time will have four open conversation.
• 02:19And so, uh, let me start by saying,
• 02:22you know we have.
• 02:24Recruited a number of leaders
• 02:27in the last year.
• 02:29Two new department chairs,
• 02:31anesthesiology and urology,
• 02:33so certainly urology.
• 02:35Relevant to this Cancer Center,
• 02:37and Isaac Kim is a prostate cancer
• 02:40specialist and then of course with great joy.
• 02:44Eric Weiner, who will start in
• 02:47February 1st as the director.
• 02:49Some other important recruits,
• 02:51I think in terms of education,
• 02:53Jessica Lousy deputy Dean Arnie
• 02:55Dante's joined us in July as deputy
• 02:58Dean of finance and administration
• 03:01and then leading now for a year.
• 03:04The work around physician scientist
• 03:06development is keep toad and associate
• 03:08Dean for HealthEquity research.
• 03:10Of course, Marcellinus Smith,
• 03:12who was also an important member of this.
• 03:15Uhm?
• 03:15This center it's been a year
• 03:18of much to celebrate.
• 03:21Joan Steitz,
• 03:22who's a member of this center,
• 03:24seems to win an award every week.
• 03:25But in particular the Wolf Prize in medicine.
• 03:30Marcelo was tapped as a member
• 03:32of the National Academy Medicine
• 03:34and Liping Chen as a member of
• 03:36the National Academy of Sciences.
• 03:40There are a. Yeah, I want to highlight
• 03:44that that we are really encouraging
• 03:47you to celebrate the accomplishments
• 03:50of not just the faculty but the staff.
• 03:52And they need not be the sort of
• 03:55standard accomplishments but can
• 03:57be good citizenship and you know.
• 03:59So in that is in the Ysm news
• 04:02and recognition which comes out
• 04:04every Wednesday morning and is
• 04:06one of the highlights of my week.
• 04:07And there's a button there at the
• 04:09bottom you can share good news,
• 04:11we've rewritten are.
• 04:13Mission statement and that was an
• 04:17extraordinary experience via zoom,
• 04:18but I think it has landed well.
• 04:21Then I won't read it to you.
• 04:22I think you have all seen it.
• 04:24We've done a lot of work around.
• 04:27Trying to make our promotion and an
• 04:30appointment process is more transparent,
• 04:33but that's work that's been led by Sam
• 04:35Ball and Jonathan Grauer and I would
• 04:38encourage you to look at the Oopd website,
• 04:41which is really quite user friendly
• 04:44and has documents such as the grid of
• 04:47the faculty tracks and the ranks and
• 04:50positions and and I think in general
• 04:53faculty associated with the Cancer Center
• 04:55have a pretty good understanding of.
• 04:58What their career trajectory looks like
• 05:00and what it what is required for promotion
• 05:03on different tracks but not always.
• 05:06And so this is a good resource.
• 05:08We have also recently been focusing
• 05:11on creating a forcing function for
• 05:13annual conversations with faculty to
• 05:15make sure that they have in meaningful
• 05:18way and you'll be hearing more
• 05:20about that in the next few months.
• 05:23Uhm?
• 05:23Heavy emphasis on leadership and on
• 05:26helping people develop their talents,
• 05:29not just in in science or
• 05:31clinical work and education,
• 05:32but in terms of executing
• 05:35on how things happen.
• 05:38Related to that,
• 05:39I think very much so are our efforts
• 05:42to enrich our community in terms of
• 05:45diversity and to create a community
• 05:47for belonging and posted on the die.
• 05:51Uh,
• 05:51office of the page now is our
• 05:55strategic plan for DI for faculty.
• 05:58Coming soon will be our strategic plan
• 06:01for students and we're in the process
• 06:03of writing the same plan for staff,
• 06:05the the fundamentals of the faculty
• 06:09plan are in fact mentorship,
• 06:12sponsorship, so really creating
• 06:15opportunities for our faculty.
• 06:19And I would say proactive.
• 06:21Mention that again,
• 06:22and this is part of the reason
• 06:24for emphasizing the importance
• 06:26of annual conversations and what
• 06:28we call stay interviews.
• 06:29But but encouraging people to.
• 06:33Seek a.
• 06:36To seek what our faculty need and to
• 06:39invest in them early and not wait until
• 06:42they've been recruited somewhere else.
• 06:45Come as part of our.
• 06:48Efforts to increase diversity.
• 06:50We have focused,
• 06:51for example,
• 06:52on retention of our students and
• 06:55our trainees into our trainees
• 06:58and our faculty and two.
• 07:02Exercises that I would highlight one is
• 07:04the intersection science Fellow Symposium.
• 07:06We just held our second in November
• 07:09where we bring some of the best and
• 07:12brightest postdoctoral fellows who
• 07:15emphasize diversity to present their
• 07:17work to a national form and also
• 07:19provide career development.
• 07:21It's a wonderful place to start to connect.
• 07:24With people we might like to recruit
• 07:27from the work of Steve Hewitt in
• 07:30India now in our residency program has
• 07:34increased our number of our proportion
• 07:37of underrepresented minorities within
• 07:39our our residents and fellowship to 24%,
• 07:41which is a significant increase.
• 07:43And now of course our work is to
• 07:46to encourage people to stay on as.
• 07:50As a faculty. In terms of
• 07:53promoting the careers of women,
• 07:55I think some of you may have seen recent
• 07:58story that we were awarded a second
• 08:00grant from the grant from the Doris
• 08:03Duke Foundation to provide funding to
• 08:05assist with COVID and and as you know,
• 08:08we invested in GAP funding during
• 08:11the COVID pandemic and our data
• 08:14suggests that has had a favorable
• 08:16effect on the careers of women faculty
• 08:19at Yale such that we don't seem to
• 08:22reflect the national average are.
• 08:23Women, in fact they have actually
• 08:25published more than her men,
• 08:26faculty and all have had a
• 08:28significant increase. Post COVID.
• 08:29Uhm?
• 08:30So we have a lot of work to do in
• 08:33terms of culture and climate and and
• 08:36much of it will involve executing our
• 08:39strategic plan in the coming years.
• 08:42In terms of education,
• 08:44we had over 6200 applications for 104
• 08:48positions and and this the student
• 08:50body is as diverse and excellent
• 08:52as it has been in recent years.
• 08:56We as you know have capped our student
• 08:59unit loan to $15,000 such that for
• 09:02those students who receive financial aid,
• 09:05the maximum debt with which they
• 09:08graduated $60,000 and the average
• 09:10debt with which medical students.
• 09:12Graduate now is
• 09:17$203,000 nationally.
• 09:20We have reversed a trend and declining U.S.
• 09:25news and World Report rankings
• 09:27and and we're number 10.
• 09:28Last year, new US News and World Report,
• 09:31of course is a very.
• 09:34Pickle and and dumb.
• 09:36I would say reputation based
• 09:39and almost magical evaluation,
• 09:40but we are working to get the word
• 09:43out about all the things that you
• 09:46are doing as I think it's extremely
• 09:48important to our incoming students
• 09:50from some of the things on the
• 09:53horizon indication one is Jessica.
• 09:55Lucy is working on changing the funds
• 09:57flow so that we truly pay those who
• 10:01are are committing significant effort
• 10:03to teaching based on their effort.
• 10:06So course directors,
• 10:09UM thread leaders,
• 10:12those who who qualified by virtue
• 10:14of the numbers of hours of teaching
• 10:17as as high intensity teachers,
• 10:19we're working to increase the
• 10:22advising support for our students,
• 10:25and Jessica is leading the strategic
• 10:29planning exercise around education
• 10:32in her first year as Deputy Dean.
• 10:35In terms of our clinical mission,
• 10:37you know it's been a complex year
• 10:40and probably nowhere more complex
• 10:43than in the Cancer Center as we
• 10:47tried to get back to the work
• 10:49that we do every day and and that
• 10:52is ensuring that our patients
• 10:55receive cutting edge therapies.
• 10:59We have a I think a tricky environment
• 11:02in healthcare and in the coming years
• 11:05we will continue to see increased
• 11:07consolidation of smaller academic health
• 11:10systems and and and and for profit
• 11:14health systems into larger systems.
• 11:17We will continue to see.
• 11:20But uh, are unique and difficult
• 11:23pressures on labor and on supply chain.
• 11:26And in order to respond to those things
• 11:28we have got to be agile and we have got to
• 11:31be very closely aligned with the system.
• 11:34So we've begun some work and it's been,
• 11:38you know, I think gaining
• 11:40momentum and and satisfying with,
• 11:42you know some ought to be honest some.
• 11:46Lapses from time to time,
• 11:47but I'm extremely optimistic
• 11:49about the direction we're taking.
• 11:51One of the first things we did and and.
• 11:54Nita and others were a member of a
• 11:57task force to codify the role of the
• 12:00chair as chiefs across the system.
• 12:03So having a line of sight over
• 12:05quality and patient care,
• 12:06and I know that this is something
• 12:08that that Eric Weiner has spent a lot
• 12:11of time thinking about in terms of.
• 12:13You know making sure that the cancer
• 12:14care that a patient that Greenwich
• 12:16gets is the same as the cancer care
• 12:18that a patient in New Haven gets,
• 12:20for example.
• 12:22The the next phase of the work is
• 12:26thinking about how we align our
• 12:29leadership structures so that we're not
• 12:32engaged in what I call parallel play.
• 12:34But we're working together as partners
• 12:37and doing strategic planning and
• 12:40empowering everybody in the mission,
• 12:43and Chris O'Connor and I praise,
• 12:47of course, is succeeding.
• 12:48Marner borgstrom this as CEO
• 12:50have begun to work.
• 12:53Formally,
• 12:53with a consultant to structure what
• 12:55that looks like and we are having,
• 12:58I think very productive conversations.
• 13:00Thinking, for example,
• 13:01about the structure of our ambulatory
• 13:04network as a shared structure
• 13:05between the system and the school,
• 13:07so much more to come there,
• 13:09but but I'm very optimistic.
• 13:14In terms of our research,
• 13:16you know last year we were
• 13:18fourth in NIH funding.
• 13:19The fiscal year has ended for NIH,
• 13:21and I think it's going to be.
• 13:24Shaken up quite a bit by some very
• 13:26large grants around COVID that were
• 13:28given and so we'll see where we land,
• 13:30but one of the things that we have
• 13:33focused on is moving from an R 01
• 13:37centric organization to encouraging.
• 13:40A collaboration and multidisciplinary grants.
• 13:45And so we set up an office for Team Science.
• 13:49Many of you have had an amazing
• 13:51year in terms of your grants,
• 13:54and it would be, I think,
• 13:55impossible to go through the whole
• 13:57list that I have in front of me.
• 14:00But just to hit a few,
• 14:01you know and and and you know
• 14:04that first K 08, for example,
• 14:07is is that first grant is really
• 14:09important than one Vasquez.
• 14:11Scott OK,
• 14:12wait this year others you know
• 14:14are more institutional grants like
• 14:17the Yale Institute of Biomedical,
• 14:20Molecular Design and Discovery.
• 14:21Getting any point?
• 14:23$5 grant. From an IG Ms,
• 14:26the training grant was renewed.
• 14:27You know, huge stuff and demayo renewed his
• 14:31American Cancer Society's research grant.
• 14:34And again, there's a long list here.
• 14:36But so congratulations and you know,
• 14:39I think that ability to pursue
• 14:41ones questions where they take
• 14:43you is just a joy that we all.
• 14:45Have come so in terms of our and
• 14:47and I would emphasize that you know
• 14:49it's not all about NIH funding.
• 14:52And of course in the Cancer Center.
• 14:54It's you know well,
• 14:55and will talk about the CTO,
• 14:57but I think you know the the importance
• 14:59of industry funding is great,
• 15:01and of course our VA.
• 15:04There are a number of institutional
• 15:06meeting university priorities,
• 15:08including neuroscience,
• 15:08and we've gotta search for
• 15:10chair of neuroscience.
• 15:11We have had strong neuroscience
• 15:14is here we have as a party of the
• 15:19institutional strategic plan.
• 15:21Institute for Information Science,
• 15:22and while this is focused at
• 15:25the core on basic science,
• 15:27we have we envisioned constructing
• 15:29this in a way to leverage
• 15:31inflammation to invest in every area.
• 15:34And so you know, cancer immunobiology,
• 15:37for example, is critical,
• 15:39and so if we call it cancer and
• 15:43inflammation to raise money,
• 15:45that's just fine.
• 15:46I am pleased that in the that
• 15:49while in the original.
• 15:51University strategic plan cancer
• 15:53didn't quite make that top five.
• 15:56The president has escalated cancer into
• 15:59the top as we have started to check
• 16:02off boxes on some of the other priorities,
• 16:05and so that is being emphasized in the
• 16:08new capital campaign that was initiated.
• 16:11Uhm?
• 16:13We have we are a bit space space constraint
• 16:16and we have to approach this in two ways.
• 16:19One of course is is building out new
• 16:21space and in addition to building out
• 16:24some wet lab space in 100 College St,
• 16:27We now have committed to building out of
• 16:29floor and 101 college St when it's completed.
• 16:32And of course we're doing renovations in
• 16:34300 George which will provide a number
• 16:37of workstations dedicated to cancer.
• 16:39We also have to manage the space
• 16:41that we have more efficiently.
• 16:44And so we have codified a space plan and
• 16:48we now are working on a master plan.
• 16:51And and some of that requires doing
• 16:54hard things like moving space
• 16:57around and and downsizing programs
• 17:00so that other programs that are
• 17:03growing can have space and that
• 17:06that will be hard work to do.
• 17:08But we need to make it transparent
• 17:10and go ahead and and do that.
• 17:13So other things that I have not
• 17:15mentioned in the research realm one
• 17:18is we have launched a search for an
• 17:21inaugural chair of an autonomous section,
• 17:24biomedical informatics and data
• 17:26science that will be critical as we
• 17:30move forward and obviously to people
• 17:32and people in the cancer world.
• 17:34You know,
• 17:35extremely important in analyzing
• 17:38large datasets.
• 17:40Also,
• 17:41we have tasked the group.
• 17:43To consider building our biorepository
• 17:46resources and that group has just
• 17:49issued a report and we are going to be
• 17:52investing in. The centralized infrastructure
• 17:55for the informatics and the cataloging and
• 17:59the standardization of handling tissue,
• 18:03and I think that will enhance resources
• 18:05that are exist in the Cancer Center
• 18:07but will make them stronger. Uhm,
• 18:09and so I think I'll stop there and again,
• 18:12that's a romp through what we talked
• 18:15about at the state of the department.
• 18:17I will get back to this issue of of
• 18:22infrastructure, purpose, search and the.
• 18:26Clinical trials office.
• 18:28We had a town hall on this and.
• 18:33We had a candidate in town
• 18:36yesterday and today as a potential
• 18:40leader to succeed Roy as interim.
• 18:42You know Roy, who is interim as
• 18:45a permanent leader of the setio.
• 18:47We are committing a lot of.
• 18:50Money to addressing the problems,
• 18:53but it's going to require having
• 18:55the right people in the right jobs.
• 18:57And as I said during the town hall,
• 18:59it's going to require.
• 19:01Uhm?
• 19:04Professionalism and uh.
• 19:06And and real commitments on
• 19:08the part of all team members,
• 19:11including faculty, to making this work.
• 19:15Uhm? Lastly, at before we get to
• 19:19the question and answers I I just
• 19:21want to say a very deeply felt.
• 19:24Thank you to Nita who has.
• 19:27Two more months. In this role,
• 19:32and has been just outstanding in jeopardy.
• 19:35The Cancer Center forward and.
• 19:39I I just can't say enough about that so.
• 19:43Will open up for questions.
• 19:46So thank you, Nancy, that was
• 19:48quite comprehensive and and I
• 19:50think also recognizing all
• 19:51the accomplishments of our
• 19:53teams and all the pillars.
• 19:54It has been a remarkable year in many ways.
• 19:57Be pad or highs and also
• 19:59some of the hard stuff.
• 20:01Before I sort of open it up for
• 20:03the to the rest of her group,
• 20:05maybe one comment or question
• 20:07from you is your thoughts.
• 20:10In some ways if we look at the care
• 20:12delivery and you mentioned this briefly
• 20:14as the consolidation of health.
• 20:17And when we look at the Cancer
• 20:19Center in in whether it's the
• 20:21smile and the care teams,
• 20:23we are very distributed care
• 20:25delivery team and the the part that
• 20:28perhaps we have had discussions
• 20:30on is how does the academics look
• 20:33like when 50% of our care gets
• 20:35delivered in these care centers?
• 20:37And how do we engage that and make
• 20:39that as one would be nice to hear what
• 20:41your thoughts are on on that and how.
• 20:44What should our future be?
• 20:45I know Eric is also on this.
• 20:47Calling it,
• 20:48maybe it's conversation.
• 20:49It's not a solution,
• 20:51but it's certainly a something
• 20:53for us to sort of say what.
• 20:55What do we see that future looking like?
• 20:57You know I have very general
• 20:59ideas about how we do that across
• 21:01the school and the institution,
• 21:03but Eric has been extremely
• 21:04thoughtful about this and if I don't
• 21:07mind if I put you on the spot or.
• 21:11Uh, whether I mind or not,
• 21:13I think I am on this spot.
• 21:15So no, I don't mind.
• 21:18I think the care centers are absolutely
• 21:20critical to the Cancer Center.
• 21:22I think cancer care is and will be
• 21:25changing more in the years ahead
• 21:28and people are simply people.
• 21:30That is, our patients are simply not
• 21:32going to be willing to come into a
• 21:35major academic center and spend 8
• 21:37hours waiting in the infusion room
• 21:38to get their three hour infusion.
• 21:41And I think we really have to
• 21:44distribute care in places that
• 21:46are closer to where they live.
• 21:49But at the same time we have to
• 21:52have those places well integrated
• 21:54with the main campus,
• 21:56and in my mind one of the huge
• 21:59opportunities we have as a Cancer
• 22:01Center is the fact that we have
• 22:04these 15 care centers and the key,
• 22:06and it seems that everyone
• 22:07is really on the same page.
• 22:09Here is we want there to be
• 22:13essentially full integration,
• 22:15a great deal of communication
• 22:17and the ability to provide.
• 22:19Great care around the state and do
• 22:22that in a research setting where
• 22:24we can enroll people in trials.
• 22:27Uhm, and you know,
• 22:28do the best for our patients
• 22:30at the same time.
• 22:31Have colleagues here and
• 22:33people around the state who
• 22:36are thrilled to work as part
• 22:38of our program.
• 22:41Thank you Eric and then this question.
• 22:44I think it's come up in many people and
• 22:46you've spoken around this in the past.
• 22:49I think many people have said the pandemic
• 22:52effects are felt more on women in in
• 22:55terms of impact on research and and.
• 22:57Can you briefly you've talked a
• 22:59little bit about the code but maybe
• 23:01highlighting all the efforts that are
• 23:02going in the School of Medicine around
• 23:04recognizing the effects that make. Yeah
• 23:07so several things, you know.
• 23:10I think it's. It's just magnified.
• 23:15The extent to which women are caregivers
• 23:18and families and and the the. Uh.
• 23:24Importance of. Of.
• 23:28Taking that into account,
• 23:29and things like, uh, appointments
• 23:32and promotions and and facilitating
• 23:35support for that so you know,
• 23:39during the pandemic, the.
• 23:43The. Obvious things like
• 23:46increased straight lengthening,
• 23:48the tenure clock and and what we do.
• 23:52All that you know always is grant
• 23:56leads for things like childcare.
• 23:59But there is a conversation ongoing
• 24:02with the Provost about increasing
• 24:05our child care benefits across the
• 24:08board in the university even further.
• 24:13I think I my experience
• 24:16and looking at the UM.
• 24:19Impact of some of the career development
• 24:21programs that we're investing in is
• 24:23that they have a greater impact on
• 24:25the careers of women and minorities or
• 24:27the greatest impact on the careers of
• 24:30women and minorities because they come.
• 24:33Create. First of all,
• 24:38transparency but. A.
• 24:41A community for people to seek
• 24:45advice about common things.
• 24:48And as an example,
• 24:49you know women thinking about where how
• 24:52we go to meetings and how we network the
• 24:55conversation will inevitably turn to.
• 24:57Well,
• 24:58how do I travel when my kids are,
• 25:00you know,
• 25:01young and problem solving that
• 25:02you know often doesn't come
• 25:05from programmatic solutions.
• 25:06It comes from being in a room with other
• 25:09young women or older women who have
• 25:12solved that problem and have great advice.
• 25:16In terms of money.
• 25:18I mentioned that the GAP funding.
• 25:22Efforts and.
• 25:25The other thing this sponsorship that
• 25:28I mentioned you know we are sending.
• 25:33Faculty to Wamc, both through programs
• 25:37for women and programs for minority,
• 25:40and also to Elam, which is an executive
• 25:42leadership in academic medicine.
• 25:44In the past, when we would do that,
• 25:46we would send people they
• 25:48would get these great.
• 25:49Ideas about how to move their career
• 25:51forward and then they come back
• 25:53and nothing came of it and so one
• 25:55of the things that we're doing is
• 25:56trying to create networks of the
• 25:59graduates of those programs and
• 26:01and groom them for leadership.
• 26:03Or, you know,
• 26:05or scientific leadership in a way
• 26:07that perhaps we haven't before,
• 26:11so those are a few of the things that we do.
• 26:14Thank you so much. Diana Krause.
• 26:16Had a question, Diana, do you want
• 26:17to ask Dean Brown yourself or I can
• 26:19read it whatever you feel comfortable,
• 26:21no big deal.
• 26:21I just I was curious to know a little
• 26:23more specifically about stands for 101.
• 26:27There gonna be wet labs what?
• 26:28Which research priorities do
• 26:30you have for that space?
• 26:32Yeah, so the original plan was that it
• 26:34would be all wet labs and then we got
• 26:37we hit a bit of a speed bump in that.
• 26:40We cannot apparently build a bridge from
• 26:43100 to 101 and for New Haven reasons.
• 26:47Which then creates my very own problems.
• 26:49And So what we're looking at now
• 26:51is the possibility of whether
• 26:52we can put a tunnel underneath.
• 26:54Because, of course,
• 26:55there's the roadway underneath,
• 26:56and there may be space to put a tunnel,
• 26:59so that's what we're trying to
• 27:00work on now to enable us to.
• 27:04To not have to build another
• 27:07variant if we put wet labs there.
• 27:10So it's a little bit in flux.
• 27:11That is the goal.
• 27:12That is where we are more.
• 27:15Where we need more space
• 27:17workstations? Thank you. So
• 27:21Catherine Harvey has a wonderful question,
• 27:23which I think is on mind
• 27:25of many folks which is.
• 27:27Maybe it's it's a long question,
• 27:29but I think the the gist of it is how do
• 27:32you balance the in person in the zoom?
• 27:34Because zoom is great if you're in
• 27:36the network, but then there's a huge
• 27:38connectivity you see in in person.
• 27:40So how do we think about balancing
• 27:42those two formats? Yeah,
• 27:44I mean this may be more of
• 27:45a question for the group.
• 27:46I'll give you my two cents and
• 27:48it comes up all the time in.
• 27:51Conversations that are typically called
• 27:52the future of work among kind of Yale.
• 27:55You know, vice presidents and administrators,
• 27:57and I think the best thing
• 28:01about COVID is that it has.
• 28:04Forced all of us to do things
• 28:06we were reluctant to do before.
• 28:08You know, no one knew how to use zoom.
• 28:11And, uh, and the and the university
• 28:14had until recently a policy that said
• 28:17you couldn't hire people who worked.
• 28:20Who lived somewhere else, right?
• 28:23We are not going back.
• 28:25To the past we will have versions
• 28:28of hybrid works for our staff
• 28:30and and there'll be more coming
• 28:33about that sort of differentiating
• 28:34the types of work that staff do,
• 28:36but I I see that the best solution is some
• 28:40sort of mix where you choose those meetings.
• 28:43That were fast, virtually,
• 28:45and you have a select group
• 28:48of smaller meetings,
• 28:49perhaps where you're in person.
• 28:53Where you get those opportunities
• 28:55to have the hallway conversation
• 28:58and make the connections,
• 29:00and we probably need to make
• 29:01more of an effort to,
• 29:03you know,
• 29:04walk from office to office and
• 29:06actually greet people.
• 29:10Uhm, Roy Herbst I think
• 29:11has a question next Roy
• 29:13yeah. Hi Nancy, one of the
• 29:15things I've noticed you know,
• 29:16working with the spores and with the
• 29:18CEOs we have so much data and we have
• 29:20so many specimens and no one of our
• 29:22great learning steps is analysis of
• 29:24those specimens with bioinformatics.
• 29:25So I was glad to hear you mentioned
• 29:27that and are doing this search.
• 29:29And certainly for us to sort of grow,
• 29:31collaborate with other groups,
• 29:33maybe get some of this operation
• 29:34money if or whatever.
• 29:35It would be great to be able to to
• 29:37be ready and pass out to do that.
• 29:38So can you tell us a little
• 29:39bit more about what the.
• 29:40Plans are for bioinformatics and how
• 29:41it will impact us on the Kansas side,
• 29:44so we have a great search committee
• 29:49that incorporates everybody
• 29:51from those who are doing.
• 29:54Uh, work with electronic health
• 29:56records to those who are doing.
• 29:59Uhm, big datasets, uh oh, mix of all flavors.
• 30:05Uhm, I would say we're not going to find.
• 30:07I don't believe we're going to find.
• 30:10You know a single person who
• 30:12does all the things that we need,
• 30:13what we're what we do want
• 30:15to find is a leader.
• 30:16Who can facilitate the work of others,
• 30:19and the idea was to set up a department
• 30:21rather than another Century Institute.
• 30:24Because as we spoke with stakeholders,
• 30:26there was a feeling that there really
• 30:28was a need for an academic home.
• 30:31There is a small academic home
• 30:33for some flavors of those people.
• 30:36As a section of Biostatistics.
• 30:38Now in YS pH and I,
• 30:42I know that Stan is on the call
• 30:44and he and I have talked about.
• 30:47The notion that this new department
• 30:49could actually be a joint department
• 30:51of our two schools and move those
• 30:54folks into this new department.
• 30:58The the types of people that we haven't
• 31:03done our airport interview yet,
• 31:05but I mean there are several,
• 31:07you know, kind of National Academy
• 31:09member type people among the list and
• 31:11it's a good group and I I think we.
• 31:16We will create an academic home
• 31:18for the types of people we also
• 31:19have to train people you know.
• 31:21There's just a dearth of.
• 31:23Faculty who can handle.
• 31:27Multidimensional data and know
• 31:29something about the diseases and.
• 31:31You know you know genetics or you know
• 31:34you can think of or no happy or not.
• 31:37You know 'cause it's really.
• 31:37It's about being trilingual or UM.
• 31:40And so we do have a new fellowship
• 31:44that's in collaboration with
• 31:46Boehringer Ingelheim to create
• 31:49data scientists and we pair them
• 31:52with a Yale interana by mentor.
• 31:55And I think those kinds of programs
• 31:57will be extremely important to us.
• 32:02Donna.
• 32:05Hey.
• 32:07Yes, and I'm glad that we're still
• 32:09on the topic of data science,
• 32:11and I'd really like to make the case
• 32:14that the Department of Biostatistics
• 32:16at the School of Public Health is
• 32:19already the home for data science
• 32:21and already doing Health Sciences,
• 32:23informatics and omics and electronic
• 32:26health record type analysis and
• 32:29has the sort of technical computer
• 32:33science and mathematical background
• 32:35to continue leading in that.
• 32:37Role in bringing in like PhD
• 32:40data scientists into the medical
• 32:42school in a different department,
• 32:45I think is almost like putting
• 32:48them as a fish out of water.
• 32:50And you know, we have Eric here and Eric,
• 32:53you know it's coming from
• 32:55Harvard as I also did.
• 32:56And you know there were some
• 32:58issues with the Harvard Biostats
• 32:59Department and there's this separate.
• 33:02You know, all mixed group under
• 33:04Zak Kohane at the medical school.
• 33:06And you know,
• 33:07some competition.
• 33:08And not necessarily the best synergy,
• 33:11whereas at the Dana Farber there's the group
• 33:14led by I was led by Giovanni Parmigiani,
• 33:17and I think he's stepped down
• 33:18and I can't remember who's,
• 33:20oh, I know who it is.
• 33:21Rafael Arisara has taken over and they
• 33:24are very tightly integrated into the
• 33:28Department of Biostatics Statistics.
• 33:30That's where their primary appointments are
• 33:32and everything is very well integrated.
• 33:35And personally I think that's
• 33:36a much better model and I.
• 33:38Hope we can move in that direction.
• 33:40I know that the Biostats department
• 33:42is even thinking of changing
• 33:44its name as many other biostat
• 33:47departments have around the country to
• 33:50Biostatistics and health data science.
• 33:52In order to further emphasize like
• 33:55the leadership role in omics and
• 33:57neural imaging and electronic health
• 34:00records and other big data types of
• 34:03methodologic and applied pursuits.
• 34:06Yeah, thank you I.
• 34:07I think this is something that
• 34:09we did a a good bit of, uh.
• 34:12A serving of all of the people
• 34:15in this space and stakeholders,
• 34:17and I've spent a lot of time
• 34:20talking with you about this,
• 34:22and I think what you're getting,
• 34:25what you're addressing is,
• 34:26you know, do you?
• 34:27Do you want to have two departments
• 34:29in two different schools?
• 34:31And the answer is no.
• 34:32They have to have a different phenotype
• 34:35and and they have to be highly collaborative.
• 34:39And you know, Even so,
• 34:41as we think about.
• 34:43You know the the.
• 34:45Put possibility of a completely
• 34:48autonomous Yale School of Public Health
• 34:51and we think about Biostatistics.
• 34:54You know,
• 34:55I think we and imagine.
• 34:57A model where those who
• 35:00are doing national logic,
• 35:02file statistics and PhD sciences
• 35:05in Biostatistics would have their
• 35:07home in the in the department
• 35:08in the School of Public Health.
• 35:10But those who are supporting
• 35:14Biostatistics in many of our
• 35:17clinical trials and other areas
• 35:19might have appointments in
• 35:20the School of Medicine and a
• 35:22secondary appointment invested.
• 35:23So we're putting a lot of thought into that,
• 35:26and I appreciate your.
• 35:28Thoughtfulness.
• 35:31Bob Garafolo had a question
• 35:32next, Bob. Loading brown,
• 35:36UM. My question relates to one of
• 35:39the aspects of the six essential
• 35:41characteristics of the CCSG.
• 35:44So one of those is institutional
• 35:46commitment and under institutional
• 35:48commitment in the in the recent FOS.
• 35:52Is that is the
• 35:53line that recognition
• 35:54of team science?
• 35:57Recognition of participation
• 35:59in team science and institutional
• 36:00policies, including those related
• 36:02to promotion and tenure. So
• 36:06the push to increase team
• 36:08science is certainly in line with this.
• 36:11My question is whether
• 36:13there's a corresponding recognition of
• 36:15team science in promotion policies.
• 36:17You know, being able to document this
• 36:19in the in the renewal as we go forward
• 36:21will lay its strength to that that
• 36:23particular aspect of the grants. Yes,
• 36:27absolutely. I think the.
• 36:31The place that we.
• 36:36Have the sort of longest conversations
• 36:40about this is in TCBS, because that's a.
• 36:44That's a group that is more accustomed to.
• 36:48The individual scientist, but uhm.
• 36:52As we promote team science on promotions
• 36:55and a appointment committees,
• 36:57what becomes critical are the
• 37:00letters of support and the letters.
• 37:03Being able to say to call out the
• 37:07important contribution that a faculty
• 37:09member has made to that team science.
• 37:11What was their unique contribution and
• 37:13and I am seeing this working actually
• 37:16pretty well in our promotion and
• 37:18appointment and promotion committees.
• 37:23Thank you, thank you and Bob.
• 37:25As you know Nancy is there a deeper
• 37:27research versus has LED us through
• 37:29renewals and is actually stepping
• 37:31down at the end of the year?
• 37:32And yes, and it's taken over.
• 37:34So yes, we appreciate all of this
• 37:36hard work tariffs amped has a
• 37:38question she just posted in chat
• 37:40about the great resignation terror.
• 37:42Do you want to ask the question?
• 37:43Yeah hi thanks Dean Brown for coming today.
• 37:45It was great talk. You know,
• 37:49I just wrote in the chat that we've
• 37:51heard a lot and read a lot and witnessed
• 37:54even the great resignation phase of
• 37:56this pandemic and just curious your
• 37:59thoughts on on this as it relates to
• 38:03Yale Medical School in the hospital.
• 38:05What we can do to support
• 38:06each other through this time?
• 38:09You know a lot of our units are having
• 38:13staffing crisis and people are tired and
• 38:15and so just curious on your
• 38:17reflections on this and what
• 38:19we can do to move forward as an
• 38:21intact unit. Yeah, thank you.
• 38:23A really important question.
• 38:27I've had a number of conversations.
• 38:28I think the has this really particularly
• 38:31affects the hospital and nursing
• 38:33and very specialized nursing,
• 38:35but of course it's what we're
• 38:37seeing in the CTO as both both
• 38:41the great resignation and the the
• 38:45the competition now nationally
• 38:46because people can work anywhere.
• 38:51I think there are this sort of
• 38:53obvious things, and then there are
• 38:54the things that may not be obvious,
• 38:55but that are equally important,
• 38:57so providing adequate
• 38:59salaries is an obvious thing,
• 39:01and we're doing a lot of work to
• 39:04reclassify some of those critical jobs.
• 39:07We being in the School of Medicine
• 39:09and the university the hospital is
• 39:10doing the same thing. Uhm, the.
• 39:15What is very important to people?
• 39:17More than money is quality of life
• 39:20and and control of times right?
• 39:24I mean that's what people got during
• 39:26the pandemic when they were working
• 39:27from home is a little more flexibility.
• 39:29So I think we equally have
• 39:32to be creative about UM.
• 39:35Providing that flexibility and then
• 39:38the last piece is some respect.
• 39:41And making sure that people feel
• 39:44like they are part of a team.
• 39:47Uhm, and that when you're under
• 39:51pressure as a physician or a
• 39:55surgeon and that it's very.
• 40:00Easy to fly off the handle.
• 40:02That is the time that we
• 40:04have to step back and say.
• 40:06This person is also under pressure and
• 40:08we need to work through this together and
• 40:11I need to behave in a professional way.
• 40:14And if there are triggers that you know I,
• 40:17I think we all have to be very
• 40:19conscious and being kind to
• 40:20each other and I'm respectful.
• 40:25Thank you Terra.
• 40:26Great question and one that's very
• 40:28much on top of everyone's mind.
• 40:30A question from our Mayor Zaidan,
• 40:31who is one of our associate professors
• 40:34and important stakeholder in the
• 40:37clinical trials arena. A matter.
• 40:38Do you want to ask the question?
• 40:39Maybe in your own words,
• 40:41so I probably won't do it justice.
• 40:44Sure, yeah, so I thanks for the Dean for
• 40:46taking the time to take our questions.
• 40:48My question in terms of all the
• 40:50challenges we had with the CTO.
• 40:52So what is the long term vision
• 40:54for Yale and Doctor Weiner?
• 40:56If you know, feel free to chip in as
• 40:58well in terms of how we are going to
• 41:01distinguish ourselves within this,
• 41:02you know the clinical research in cancer.
• 41:04There are different ways in which
• 41:06different centers. Uhm, do this.
• 41:09And how is the incoming CEO?
• 41:11Director associate director
• 41:13is envisioning this.
• 41:15It would be great if the process for
• 41:17choosing that person is more inclusive
• 41:19and we get a sense of what is their
• 41:22vision statement for the specifics
• 41:23they hope to accomplish and the
• 41:25timelines they hope to do that over.
• 41:27Thank you.
• 41:27OK, I'm gonna talk generally and
• 41:30then Eric watched the correct
• 41:32anything that I say he can.
• 41:34He can step in but uhm.
• 41:36I think the key thing about the
• 41:38next leader of the CTO is that
• 41:41this cannot just be person.
• 41:43A person who is.
• 41:45Working to get the trains running on time,
• 41:49but that that needs to be done
• 41:51that is fundamental, but.
• 41:52One of the reasons that we have issues is
• 41:57we have not paid attention to fundamentals.
• 42:00We've not adequately.
• 42:02Uhm?
• 42:02Trained all of our incoming investigators.
• 42:06We've not adequately sunsetted old proposals.
• 42:10We you know,
• 42:11haven't done that kind of structural thing,
• 42:13so I think the the incoming
• 42:16CTO director also has to be.
• 42:18Uhm?
• 42:20Someone who has real.
• 42:25Bonafede A as a clinical investigator
• 42:28and as somebody who has has
• 42:32done designed clinical trials.
• 42:35Knows how to design them well.
• 42:38To test hypotheses and not just be
• 42:41descriptive, so that's one issue.
• 42:43Beyond the CTO, and is are much
• 42:47larger institutional issues that we
• 42:50have in terms of the infrastructure.
• 42:53For things like contract ING and we are
• 42:57having a conversation that how to get better.
• 43:01Oversight in the School of Medicine
• 43:03over clinical contract ING.
• 43:04When we are the primary user of that.
• 43:08Uhm, and when the considerations
• 43:10are very different.
• 43:12Then they are for you know,
• 43:14contract ING or something in the in
• 43:16the other side of the university.
• 43:22Eric. Sure, uhm. So
• 43:27I don't think there's a simple
• 43:29answer to your question.
• 43:31I would agree with Nancy very
• 43:35strongly that there really.
• 43:37In many ways, two separate issues.
• 43:39One is getting the trains going
• 43:42again and we need somebody who's
• 43:44going to be able to work with
• 43:46everyone here and make that happen.
• 43:49And then we we need as you
• 43:51suggest in your question,
• 43:52really a broad view of of clinical research.
• 43:57And we do have somebody here
• 44:01interviewing somebody who I know
• 44:03well and who is spending time with
• 44:07approximately 30 different people today,
• 44:10tomorrow and by zoom and.
• 44:14I think that that in and of itself is a is
• 44:17a meant to be a very inclusive process,
• 44:20but I think there's some urgency in
• 44:22filling this position and it's not
• 44:24something that can drag on for a long time,
• 44:27so I will share with you that I
• 44:30fervently hope that people like this
• 44:32person and that we're going to be able
• 44:35to move forward in the short term.
• 44:37I think to ask anyone whether
• 44:40it's me or whether it's the new
• 44:43CTO director to provide a.
• 44:45Broad vision for clinical research at this
• 44:48moment is probably a little too soon,
• 44:50but I think it's a very reasonable question
• 44:53and you know the truth is we want to.
• 44:56We want to be able to design the very best,
• 45:00most creative,
• 45:01most impactful clinical trials that will
• 45:04each answer many different questions.
• 45:08Working closely with you know all
• 45:11of the various disciplines and
• 45:13with you know outstanding.
• 45:15Help from our biostatistical
• 45:18colleagues and more than that,
• 45:20they really need to be trials that
• 45:23allow us to reach into the lab
• 45:25and reach into a whole variety
• 45:27of areas so that you know we're
• 45:30not asking empiric questions,
• 45:32but we're really trying to
• 45:34understand the basis of disease.
• 45:35So I mean,
• 45:36that's a pretty broad answer and
• 45:38I'm sorry I can't be more specific,
• 45:41but I think that we're going
• 45:44to distinguish ourselves by
• 45:46having extremely thoughtful,
• 45:48unique trials that we,
• 45:50as a group put together.
• 45:53So I think you know, obviously a
• 45:55rather large question and you know,
• 45:57we've all alluded to some of the things that
• 45:59are general to the national conversation,
• 46:02which is the people and some some of
• 46:04the big things that are unique to us,
• 46:06which are the structural challenges,
• 46:08whether it's contract ING and some of
• 46:11the things that Nancy has alluded to,
• 46:13how do we think about portfolio management?
• 46:16Resource management?
• 46:16Think the piece on vision and how
• 46:19clinical trials are fundamentally is.
• 46:21One of our Cancer Center, right?
• 46:24The cancer.
• 46:24Enter as many departments that are part
• 46:27of this and how do we take the best of
• 46:29our science and translate that into
• 46:31meaningful things for our patients?
• 46:32So I think these are important
• 46:34questions and one fundamentally
• 46:36beyond the leader will also come
• 46:38from a lot of the people on on this
• 46:42town hall as how we think about the
• 46:44next generation of her clinician
• 46:46investigators and also our patients.
• 46:48So again,
• 46:49good question and there's a candidate
• 46:51here who has met many folks today
• 46:53that could be one more thing.
• 46:56Just
• 46:56that I think this is, I think,
• 46:58clinical trials are the ultimate
• 47:00example of team science.
• 47:01You know this is not something that
• 47:03any individual can do on their own.
• 47:05I'm not talking about the the director,
• 47:07I'm talking about all of us doing
• 47:09trials and they benefit from our A
• 47:12really comprehensive group effort.
• 47:15Thank you Doctor Weiner and I have a
• 47:17question from Doctor Helene. Stephanie.
• 47:19Sure you know
• 47:20this is interview season.
• 47:21You know for fellows
• 47:23for MD PhD students for Residency
• 47:25Fellowship, and you know,
• 47:27in our current fellows frequently asked,
• 47:30what is my career path, right?
• 47:31Where do I go and what can
• 47:33we do to improve support?
• 47:36Where you for
• 47:37this very, very critical
• 47:38time of advancing from fellowship to
• 47:41junior faculty and guide their path?
• 47:44The Institute is a chamber
• 47:45society. I'm curious,
• 47:47you know about more initiatives like that.
• 47:49Yeah, So what?
• 47:50I'll go through some of the other
• 47:52things that keep choke has established.
• 47:55That that Janeway society is not
• 47:57just kind of a social group,
• 47:59it's it's a UM. Very impressive.
• 48:03He's meeting with every
• 48:04single member of that group.
• 48:06It creates an oversight of mentorship
• 48:09which is extremely important.
• 48:11Even though you think people
• 48:12are getting good mentorship,
• 48:13you start to learn that there are
• 48:15holes that they may not be meeting
• 48:17with their mentorship committee
• 48:19and that oversight of mentorship
• 48:21improves outcomes in and of itself.
• 48:23The Janeway Society then gives an
• 48:26opportunity to have conversations around.
• 48:29The soft skills that all of us wish that
• 48:31somebody had shared with us, right?
• 48:33You know how do I talk to my mentor?
• 48:35How do I hire?
• 48:37For my laboratory,
• 48:39what's the right time to do?
• 48:41You know, whatever?
• 48:43Embedded in that also are an extension
• 48:47of a grant writing course that Jean
• 48:49Shapiro has offered for many years,
• 48:51and an extension of a uhm.
• 48:55Manuscript writing course and now
• 48:56you get people in that group saying,
• 48:59ah, I I did that and it's and I,
• 49:02you know,
• 49:02my manuscript was accepted in nature
• 49:04or whatever it is that starts to
• 49:06create a buzz around that thing.
• 49:08He has rolled out a a repository
• 49:13of successful grants.
• 49:15So your young faculty member who?
• 49:21Is writing his or her first arawan
• 49:23can can pull up all of the successful
• 49:26are ones in recent years and read
• 49:29them and learn from their response to
• 49:32reviewers how to do a revision for example.
• 49:36Uhm, he has just started.
• 49:40I think they rolled out and I don't
• 49:42think it's met yet, but the first.
• 49:45Uh,
• 49:45studies internal study section for
• 49:47people who are submitting grants,
• 49:50and we have 11 people who have submitted.
• 49:53I think eight are ones and three
• 49:55other flavored grants to be reviewed
• 49:57by this inaugural study section that
• 50:00will be offered before each cycle.
• 50:02Uhm? And then of course, money, right?
• 50:05So you guys have a K12,
• 50:07but there are there are in there.
• 50:09So making those things available to faculty.
• 50:12But we have now funding for that T
• 50:16to K conversion that is available
• 50:19on an annual basis.
• 50:20And so as you start to say those
• 50:23things to young incoming faculty,
• 50:25they start to appreciate that this
• 50:27is an institution that values
• 50:28and values their career success.
• 50:30And in my experience you not only
• 50:32recruit those people, you start to.
• 50:33Use that as a way to recruit shares,
• 50:35because they realize that they will
• 50:37have support for the investments that
• 50:40they're making in young faculty.
• 50:44Thank you.
• 50:47I'm just looking at the chat if there
• 50:49are other questions while there are,
• 50:51I'm going to ask you one because
• 50:52I asked this in surgery.
• 50:53What's your favorite part of yeah?
• 50:55What made from your days as an undergrad?
• 50:58God, you know, I, I think I don't
• 51:01even remember what I said that time.
• 51:04I you know so I live on the other side of
• 51:06campus and I love walking to work every
• 51:09day in this beautiful campus on say that.
• 51:11I love being around a lot of smart people.
• 51:15I will inform you guys every day.
• 51:18Yeah, and of course we had the
• 51:19Harvard Yale game this weekend,
• 51:20so that was not so good.
• 51:22It was. It was a close one so.
• 51:26It I see, Roy Herbst has one
• 51:28more question, Doctor Herbst.
• 51:31Well, I I have one more question.
• 51:33Well first of all, for the clinical
• 51:34trials I agree with what Eric said,
• 51:36but I also want to point out that it's
• 51:38really a dyad between the physician
• 51:39director and the administrative team.
• 51:41And how important that group is.
• 51:43And and I want to thank them all for
• 51:45everything they're doing during this time.
• 51:46But I wanted to ask you, Nancy,
• 51:48now that you've been here for awhile,
• 51:49one of the important things
• 51:50about clinical trials,
• 51:51it would be to take our aryel
• 51:53science and bring into the clinic.
• 51:54And I'm wondering what you think about some
• 51:56of our greatest strength scientifically.
• 51:58And you know, in the center and what
• 52:00are the gaps that you'd like to?
• 52:01Bring in to enhance.
• 52:04Well, I I think it's fraught to
• 52:06say what's our greatest science,
• 52:07because you inevitably will
• 52:08leave something out.
• 52:12You know, uhm? The strength of
• 52:14the basic science here was one
• 52:17of the things that attracted me.
• 52:19Uh, I think I was not aware of the
• 52:21extent to which we had clinical
• 52:23investigation going on and you and
• 52:25I have talked about there are.
• 52:27There are some gaps we have.
• 52:30Not trained people in.
• 52:33Uhm, hypothesis testing,
• 52:35early translation very well.
• 52:39We've let them learn by the
• 52:40seat of their pants,
• 52:42and so I think we have opportunities to.
• 52:48Enhance our bidirectional translation.
• 52:50And nobody does this better
• 52:54than than oncology and.
• 52:57But we need to do that across the
• 52:59board and in all of our science.
• 53:07Nancy was a really great session.
• 53:09As you saw from all of the Q&A that we had,
• 53:12I want to thank you for making
• 53:14this an interactive format.
• 53:16I want to thank everybody for attending.
• 53:18I think couple reminders or
• 53:19actually just one reminder.
• 53:20We do have town hall next on Thursday,
• 53:24December 2nd at 5:00 PM.
• 53:26Kevin Billingsley and the team
• 53:28will be talking about our quality
• 53:30metrics for the coming year.
• 53:32So just reminder to put that in
• 53:35your happy Thanksgiving everybody.
• 53:37And have a great rest of the day.
• 53:38Take care, thank you, thank you.